Florida Pharmacy Technician CE Requirements for 2026
Florida pharmacy technicians must complete 20 total continuing education (CE) hours by December 31, 2026 to renew their Registered Pharmacy Technician status with the Florida Board of Pharmacy. The biennial requirement includes 2 hours of Board-approved medication error CE, with the remaining hours fulfilled through general ACPE- or Board-approved courses that count toward Florida’s renewal. CE Broker is the official tracking system for reporting completed credits.
Embracing AI Innovations: The Digital Clinician
A recent phase 2 clinical trial suggests that azelastine nasal spray, a common antihistamine used for allergic rhinitis, may reduce the risk of SARS CoV 2 infection. Researchers observed lower infection rates and fewer symptomatic cases among participants using the spray. Although these early findings are intriguing, larger studies are needed before azelastine can be recommended for routine COVID prevention.
Level Up Your LAI Practice: Building Confidence with Long-Acting Antipsychotics
Long-acting injectable antipsychotics can improve adherence and outcomes, but many pharmacists lack confidence navigating their complexity. This ACPE-accredited CE series led by Dr. Tammie Lee Demler equips pharmacists with the clinical knowledge, practical skills, and patient-centered strategies needed to confidently initiate, manage, and administer LAI antipsychotics in real-world practice.
From Allergy Relief to Viral Defense? Exploring Nasal Antihistamine Use Against COVID
A recent phase 2 clinical trial suggests that azelastine nasal spray, a common antihistamine used for allergic rhinitis, may reduce the risk of SARS CoV 2 infection. Researchers observed lower infection rates and fewer symptomatic cases among participants using the spray. Although these early findings are intriguing, larger studies are needed before azelastine can be recommended for routine COVID prevention.
Special Considerations for Children with Diabetes
Diabetes care for kids isn’t just “adult care in smaller doses.” From growth spurts and puberty to school lunches, sports, and mental health, pediatric diabetes requires a unique approach. Here’s how pharmacists, nurse practitioners, families, and schools can work together to keep kids safe — while letting them be kids.
Simplify to Succeed: How Fixed-Dose Combination Therapies Improve Diabetes Adherence
Managing multiple comorbidities in type 2 diabetes often leads to complex medication regimens—and poor adherence. Fixed-dose combination (FDC) therapies offer a clinically sound solution by streamlining treatment without compromising efficacy. This blog explores how APRNs can use FDCs to reduce pill burden, improve glycemic outcomes, and enhance long-term adherence.
Special Considerations for Older Adults with Diabetes
Diabetes care isn’t one-size-fits-all — especially for older adults. From medication safety and drug interactions to independence and quality of life, managing diabetes at 75 looks very different than at 45. Here’s what makes diabetes care unique for older patients.
Packing More than Clothes: The Crucial Role of Travel Vaccinations
Planning an international trip? Don’t overlook the vaccines you and your patients may need before boarding the plane. From routine immunizations to destination-specific shots like yellow fever or typhoid, pharmacists play a key role in keeping travelers protected. Learn how to use the CDC’s Yellow Book to guide travel health consultations and safeguard both personal and public health.
GLP-1 Receptor Agonists: A Game-Changer for Type 2 Diabetes, Obesity, and Cardiometabolic Health
GLP-1 receptor agonists are changing how we manage more than just blood glucose. APRNs are using these therapies to support weight loss, reduce cardiovascular risk, and improve patient outcomes across the board.
GLP-1 Agonists: Exciting Tools with Real Challenges
GLP-1 receptor agonists like semaglutide and tirzepatide are changing the conversation around weight management and blood sugar control. But with their rise in popularity comes a new wave of patient challenges—from cost and access to side effects and misinformation. In this post, we dig into the real-world barriers patients face on GLP-1s and how clinicians can support them, based on a candid (and chaotic) dinner-table conversation that might sound a lot like your own.